91 related articles for article (PubMed ID: 21447733)
21. Expression and functional activity of P-glycoprotein in passaged primary human nasal epithelial cell monolayers cultured by the air-liquid interface method for nasal drug transport study.
Cho HJ; Choi MK; Lin H; Kim JS; Chung SJ; Shim CK; Kim DD
J Pharm Pharmacol; 2011 Mar; 63(3):385-91. PubMed ID: 21749386
[TBL] [Abstract][Full Text] [Related]
22. New insights into the carrier-mediated transport of estrone-3-sulfate in the Caco-2 cell model.
Grandvuinet AS; Gustavsson L; Steffansen B
Mol Pharm; 2013 Sep; 10(9):3285-95. PubMed ID: 23834246
[TBL] [Abstract][Full Text] [Related]
23. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
24. Oral and inhaled corticosteroids: differences in P-glycoprotein (ABCB1) mediated efflux.
Crowe A; Tan AM
Toxicol Appl Pharmacol; 2012 May; 260(3):294-302. PubMed ID: 22464980
[TBL] [Abstract][Full Text] [Related]
25. Development of a highly sensitive method using liquid chromatography-multiple reaction monitoring to quantify membrane P-glycoprotein in biological matrices and relationship to transport function.
Miliotis T; Ali L; Palm JE; Lundqvist AJ; Ahnoff M; Andersson TB; Hilgendorf C
Drug Metab Dispos; 2011 Dec; 39(12):2440-9. PubMed ID: 21949244
[TBL] [Abstract][Full Text] [Related]
26. Construction of a functional transporter analysis system using MDR1 knockdown Caco-2 cells.
Watanabe T; Onuki R; Yamashita S; Taira K; Sugiyama Y
Pharm Res; 2005 Aug; 22(8):1287-93. PubMed ID: 16078138
[TBL] [Abstract][Full Text] [Related]
27. [The evaluation of efflux transporter model based on RNA interference technology in vitro].
Kong LL; Yang HY; Yuan M; Zhuang XM; Li H
Yao Xue Xue Bao; 2015 Sep; 50(9):1122-7. PubMed ID: 26757548
[TBL] [Abstract][Full Text] [Related]
28. Membrane transport of nobilin conjugation products and use of the extract of Chamomillae romanae flos influence absorption of nobilin in the Caco-2 model.
Thormann U; Hänggi R; Kreuter M; Imanidis G
Eur J Pharm Sci; 2015 Apr; 70():92-106. PubMed ID: 25477003
[TBL] [Abstract][Full Text] [Related]
29. The transport and efflux of glycosylated luteinising hormone-releasing hormone analogues in caco-2 cell model: contributions of glucose transporters and efflux systems.
Moradi SV; Varamini P; Toth I
J Pharm Sci; 2014 Oct; 103(10):3217-24. PubMed ID: 25174499
[TBL] [Abstract][Full Text] [Related]
30. Interactions between organic anions on multiple transporters in Caco-2 cells.
Grandvuinet AS; Steffansen B
J Pharm Sci; 2011 Sep; 100(9):3817-30. PubMed ID: 21607956
[TBL] [Abstract][Full Text] [Related]
31. Efflux transporters and tight junction expression changes in human gastrointestinal cell lines cultured in defined medium vs serum supplemented medium.
Warrier A; Gunosewoyo H; Crowe A
Life Sci; 2018 Aug; 207():138-144. PubMed ID: 29857072
[TBL] [Abstract][Full Text] [Related]
32. Uptake and Permeability Studies to Delineate the Role of Efflux Transporters.
Vadlapatla RK; Pal D; Mitra AK
Methods Mol Biol; 2016; 1395():69-74. PubMed ID: 26910069
[TBL] [Abstract][Full Text] [Related]
33. 3D organoids derived from the small intestine: An emerging tool for drug transport research.
Zhang Y; Huang S; Zhong W; Chen W; Yao B; Wang X
Acta Pharm Sin B; 2021 Jul; 11(7):1697-1707. PubMed ID: 34386316
[TBL] [Abstract][Full Text] [Related]
34. Knockout of ABC transporters by CRISPR/Cas9 contributes to reliable and accurate transporter substrate identification for drug discovery.
Feng D; Zhong G; Zuo Q; Wan Y; Xu W; He C; Lin C; Huang D; Chen F; Huang L
Front Pharmacol; 2022; 13():1015940. PubMed ID: 36386127
[TBL] [Abstract][Full Text] [Related]
35. Correlations of mRNA Levels among Efflux Transporters, Transcriptional Regulators, and Scaffold Proteins in Non-Small-Cell Lung Cancer.
Zhang X; Liu W; Edaki K; Nakazawa Y; Kamioka H; Fujita A; Onozato R; Iijima M; Tsuchida S; Arai T; Fujita Y; Mizoi K; Ogihara T
Can J Infect Dis Med Microbiol; 2021; 2021():4005327. PubMed ID: 34876945
[TBL] [Abstract][Full Text] [Related]
36. Study of Statin- and Loratadine-Induced Muscle Pain Mechanisms Using Human Skeletal Muscle Cells.
Leung YH; Turgeon J; Michaud V
Pharmaceutics; 2017 Oct; 9(4):. PubMed ID: 28994701
[TBL] [Abstract][Full Text] [Related]
37. A fast screening model for drug permeability assessment based on native small intestinal extracellular matrix.
Li N; Sui Z; Liu Y; Wang D; Ge G; Yang L
RSC Adv; 2018 Oct; 8(60):34514-34524. PubMed ID: 35548601
[TBL] [Abstract][Full Text] [Related]
38. The apparent permeabilities of Caco-2 cells to marketed drugs: magnitude, and independence from both biophysical properties and endogenite similarities.
O'Hagan S; Kell DB
PeerJ; 2015; 3():e1405. PubMed ID: 26618081
[TBL] [Abstract][Full Text] [Related]
39. The role of a basolateral transporter in rosuvastatin transport and its interplay with apical breast cancer resistance protein in polarized cell monolayer systems.
Li J; Wang Y; Zhang W; Huang Y; Hein K; Hidalgo IJ
Drug Metab Dispos; 2012 Nov; 40(11):2102-8. PubMed ID: 22855735
[TBL] [Abstract][Full Text] [Related]
40. BDDCS applied to over 900 drugs.
Benet LZ; Broccatelli F; Oprea TI
AAPS J; 2011 Dec; 13(4):519-47. PubMed ID: 21818695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
